Breast- p63 negative invasive breast cancer of no special type (NST)
Breast- p63 negative invasive breast cancer of no special type (NST)
Breast- p63 negative invasive lobular breast cancer
Breast- p63 negative invasive lobular breast cancer
Colon- p63 negative colorectal adenocarcinoma
Colon- p63 negative colorectal adenocarcinoma
Esophagus- p63 negative adenocarcinoma
Esophagus- p63 negative adenocarcinoma
Esophagus- Squamous cell carcinoma with intense p63 immunostaining of tumor cells
Esophagus- Squamous cell carcinoma with intense p63 immunostaining of tumor cells
Kidney- p63 negative clear cell carcinoma
Kidney- p63 negative clear cell carcinoma
Kidney- p63 negative papillary renal cell carcinoma
Kidney- p63 negative papillary renal cell carcinoma
Oral cavity- Squamous cell carcinoma with strong p63 immunostaining of tumor cells
Oral cavity- Squamous cell carcinoma with strong p63 immunostaining of tumor cells
Ovary- p63 negative clear cell carcinoma
Ovary- p63 negative clear cell carcinoma
Ovary- p63 negative endometroid carcinoma
Ovary- p63 negative endometroid carcinoma
Ovary- p63 negative serous high-grade carcinoma
Ovary- p63 negative serous high-grade carcinoma
Pharynx- Squamous cell carcinoma with strong p63 staining of tumor cells
Pharynx- Squamous cell carcinoma with strong p63 staining of tumor cells
Prostate- p63 negative adenocarcinoma (Gleason 3+3=6). Some p63 positive basal cells are visible in an atrophic normal gland
Prostate- p63 negative adenocarcinoma (Gleason 3+3=6). Some p63 positive basal cells are visible in an atrophic normal gland
Thyroid- p63 negative follicular carcinoma
Thyroid- p63 negative follicular carcinoma
Urinary bladder- Muscle-invasive urothelial carcinoma with moderate to strong p63 immunostaining of tumor cells
Urinary bladder- Muscle-invasive urothelial carcinoma with moderate to strong p63 immunostaining of tumor cells
Urinary bladder- Muscle-invasive urothelial carcinoma with weak to moderate p63 immunostaining in a fraction of tumor cells
Urinary bladder- Muscle-invasive urothelial carcinoma with weak to moderate p63 immunostaining in a fraction of tumor cells
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) showing strong p63 positivity of tumor cells
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) showing strong p63 positivity of tumor cells